Thrivent Financial for Lutherans’s BioXcel Therapeutics BTAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,500
| Closed | -$51K | – | 2519 |
|
|
2024
Q2 | $51K | Hold |
2,500
| – | – | ﹤0.01% | 2512 |
|
|
2024
Q1 | $113K | Hold |
2,500
| – | – | ﹤0.01% | 2488 |
|
|
2023
Q4 | $118K | Buy |
2,500
+1,250
| +100% | +$59K | ﹤0.01% | 2460 |
|
|
2023
Q3 | $50K | Buy |
1,250
+625
| +100% | +$25K | ﹤0.01% | 2420 |
|
|
2023
Q2 | $64K | Buy |
+625
| New | +$64K | ﹤0.01% | 2443 |
|
|
2021
Q2 | – | Sell |
-1,294
| Closed | -$893K | – | 2465 |
|
|
2021
Q1 | $893K | Sell |
1,294
-167
| -11% | -$115K | ﹤0.01% | 1946 |
|
|
2020
Q4 | $1.08M | Buy |
+1,461
| New | +$1.08M | ﹤0.01% | 1701 |
|